在COVID-19感染中发生骨髓变化:血液学问题的根源
Fatemeh Zeylabi1, Najmeh Nameh Goshay Fard2, Abazar Parsi3
1Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Current research in translational medicine
|August 6, 2023
概括
严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 感染显著影响骨髓 (BM),导致血细胞变化,如胰岛素缩小和血细胞. 这些发现凸显了BM在COVID-19病变发生过程中的关键作用.
科学领域:
- 血液学 血液学 血液学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 由SARS-CoV-2引起的COVID-19影响了造血系统和平衡.
- 病毒对血液细胞的影响表明,骨髓参与了病毒的发病.
- 研究SARS-CoV-2对骨髓的影响对于了解COVID-19的全部影响至关重要.
研究的目的:
- 综合审查由SARS-CoV-2感染引起的骨髓变化.
- 阐明COVID-19相关骨髓病理背后的机制.
- 评估COVID-19患者骨髓变化的临床意义.
主要方法:
- 关于2022年之前的研究的文献综述.
- 在谷歌学者和PubMed数据库中进行的搜索.
- 关键词包括:COVID-19,SARS-CoV-2,骨髓,血栓细胞减小,血细胞,泛细胞减小.
主要成果:
- SARS-CoV-2 感染与骨髓变化有关,包括细胞衰竭,全细胞衰竭,血细胞衰竭和亡.
- 机制包括细胞因子释放综合征,对骨髓细胞的直接病毒影响和皮质类固醇副作用.
- 这些变化表现为血液细胞数量和功能的显著变化.
结论:
- 本综述提供了SARS-CoV-2诱导的骨髓变化的全面分析.
- COVID-19对骨髓的影响比以前理解的要深刻.
- 骨髓变化是COVID-19病变和临床表现的一个关键因素.
相关概念视频
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Disorders of Leukocytes
982
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
982
Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K


